Substance P/Neurokinin-1 Receptor Antagonist
DBCAT003389Therapeutic category
A DrugBank category of 7 drugs. 7 of them are approved.
What you can answer from here — as of October 25, 2017
Which targets do Substance P/Neurokinin-1 Receptor Antagonist share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account